about
sameAs
Bevacizumab and Lomustine for Recurrent GBMBevacizumab in Recurrent Grade II and III GliomaVeliparib and Temozolomide in Treating Patients With Recurrent GlioblastomaE-MOSAIC Electronic Tool to Monitor SymptomsNovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent GlioblastomaMibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent GliomaOlaparib and Temozolomide in Treating Patients With Relapsed GlioblastomaRadiosurgery Plus Bevacizumab in GlioblastomaStudy of Blood and Cheek Cell Samples From Patients With GliomaRadiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade GliomaStudy of Tissue Samples From Patients With Glioma or Other Brain TumorsHydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive MeningiomaTumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant GliomaRamucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma MultiformeDasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma MultiformeDecision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialBevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade GliomaA Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain TumorsImaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant AstrocytomaBevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma MultiformeTemozolomide in Treating Patients With Recurrent High-Grade GliomaVaccine Therapy in Treating Patients With Malignant GliomaPhase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain NeoplasmsLevetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain TumorsObservation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III MeningiomaTemozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain TumorsBortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to TreatmentTamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord TumorsFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainSodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other CancersTemozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant GliomaO(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation TherapyMRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade GliomaTetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade GliomaTumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant GliomaImatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive MeningiomaImatinib Mesylate and Temozolomide in Treating Patients With Malignant GliomaDynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant GliomaATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma
P921
Q63814129-A51BE944-C2F5-4CAA-886C-9FCA700F6593Q63833350-3CEC9D26-618C-46C5-93E7-CE2A850F50E5Q63838957-D8E32CD1-F932-42BC-BB8D-A4E9C7BEA073Q64121103-D52539FD-78D4-4FF4-BD2F-1B273535A9F2Q64151923-501A54DF-D7A4-4BBC-8DFF-1D41CA860DFAQ64170837-53099FF0-B280-494C-88B0-ECD54387D445Q64650245-39449298-8559-43D9-8BE2-FAD1A0C02444Q64655470-A256FFCE-F007-46A2-859A-28CE9141B24AQ64660199-0690BC50-C1F4-42ED-801C-8B3A7E847EE4Q64662809-9F09ACDF-3EFF-4BD0-B8AA-0162AE80E787Q64664512-769031BA-6550-4742-B469-A9237C26BFB8Q64675846-DB613092-64AE-4799-8D0F-146E9E7DC122Q64676385-9C58E56D-EBEA-42D6-96E5-9FB503B4D562Q64677428-43813C5F-4EC7-4A73-A778-407026816ECBQ64677894-8CE30B62-31BD-48A7-AAC7-B5F4A8B1DBFDQ64678159-1219AC30-A5A1-4091-9F69-4EE79F566B4FQ64709472-1DCBC233-DBE6-44C7-AD8A-5A83AEA72545Q64710406-761211D7-E5FF-4F2E-B859-7C68B686109FQ64716452-5B05EB13-2A25-42C5-9C30-396704A89D09Q64722714-54673300-D8E5-4976-A6DA-B0D63D8CE39DQ64723054-1364F8E6-1678-4622-B0EE-31E84D7072B5Q64724081-2C35BA3E-3502-4035-9DDE-1016E049EE75Q64807530-B154DCA9-CD1D-4E96-B583-DF2260C4A9A5Q65378518-6A49941F-AE3B-4763-924B-5EF2E5885E6BQ65378764-86386839-7184-4B43-A53D-5ACAE4499B51Q65379249-A909F4C4-47C7-4D9F-8CE6-C1A9A2AC3D2AQ65379718-DCCC61DE-9E9F-44ED-9397-73DB59D2DF74Q65380209-0A93D3EB-1F16-4118-BDBD-BB4F522864C3Q65380582-7CCD3A9E-D024-4E98-8772-7197099F7ED3Q65381245-ACEB11E7-CB3A-4C3A-BABC-E26D35DDA28BQ65381253-491DF7CC-890E-41AF-BD1F-2F8EBC5892D2Q65383396-E82989F3-E507-417E-A254-AA0DF806F88FQ65383882-730C12FF-8317-46F0-B593-1C161F49573EQ65383999-FD09C1D9-921F-492B-A117-316F0639EE5EQ65385469-FA1599E1-9325-4820-805C-3A37A5822605Q65385771-5DF31F0F-2707-498B-ACF5-82D19E72C5C2Q65387210-8B84E96E-FDA4-4621-9E2F-58626E2AF440Q65387367-57670B84-FB4B-4341-9D35-7A3A2FCF1DC4Q65387639-5459726B-5F76-4CC7-B796-B5398F3A0825Q65387695-C4CE4737-87C5-41A8-A5A2-1A4AE0D6B834
P921
description
Human disease
@en
مرض يصيب الإنسان
@ar
name
recurrent adult brain tumor
@en
type
label
recurrent adult brain tumor
@en
altLabel
relapsed tumor of adult brain
@en
prefLabel
recurrent adult brain tumor
@en